Jame Abraham, MD, Oncology, Cleveland, OH

JameAbrahamMD

Oncology Cleveland, OH

Breast Cancer, Hematologic Oncology

Chairman, Department of Hematology and Medical Oncology, Taussig Cancer Institute; Professor of Medicine, Cleveland Clinic

Dr. Abraham is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Abraham's full profile

Already have an account?

  • Office

    9500 Euclid Avenue
    Taussig Cancer institute, Cleveland Clinic
    Cleveland, OH 44195
    Phone(216) 444-6833
  • Is this information wrong?

Summary

  • Professor of Medicine at Lerner College of Medicine of Cleveland Clinic and Director of Breast Oncology Program at Taussig Cancer Institute, Cleveland Clinic. Member of Breast Cancer Working Committee and Breast Cancer Translational Commitee of NRG Oncology Research Group. Principal Investigator of NSABP studies at Cleveland Clinic. Co- PI of the NCI CTN - LAPS grant at case comprehensive cancer center.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1997 - 2001
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1994 - 1997
  • Calicut Medical College
    Calicut Medical CollegeClass of 1991

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2021
  • WV State Medical License
    WV State Medical License 2000 - 2014
  • CT State Medical License
    CT State Medical License 1996 - 2001
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Certificate for one of Highest Accruing Principal Investigators in the Country, CTEP National Cancer Institute, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Palliative Care Training during Fellowship: A National Survey of US Hematology and Oncology Fellows  
    Thomas RA, Curley B, Wen S, Zhang J, Abraham J, Moss AH,, J Palliat Med, 1/22/2015
  • Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in wome...  
    Abraham J, Robidoux A, Tan AR, Limentani S, Sturtz K, Shalaby I, Alcorn H, Buyse ME, Wolmark N, Jacobs SA, Breast Cancer Res Treat, 1/1/2015
  • Radiation Exposure in Patients with Newly Diagnosed Breast Cancer within First Year from Diagnostic Procedures  
    Chaudhary L., Knapp S., Hester S., Wen S., Xiao J., Marano G., Kurian S., Hazard H., Layne G., Jacobson G., Abraham J., Journal of Community and Supportive Oncology, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Graded Prognostic Assessment (GPA) for Her2 positive Breast Cancer with Brain Metastases (BCBM) in a Contemporary Cohort.
    Chi M, Venur VA, Mohammadi AM et al, American Society of Clinical Oncology (ASCO), 1/1/2015
  • New graded prognostic assessment (GPA) in breast cancer brain metastases in a contemporary cohort.
    Ahluwalia M, Chi M, Venur VA, Budd T, et al, San Antonio Breast Cancer Symposium (SABCS), 1/1/2014
  • Graded prognostic assessment for triple negative breast cancer brain metastases.
    Chi M, Venur VA, Abraham J, Budd T et al, San Antonio Breast Cancer Symposium (SABCS), 1/1/2014
  • Join now to see all

Lectures

  • NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib (N) in women with metastatic HER2+ breast cancer (MBC). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Management of Metastatic Breast Cancer. 
    1/10/2015
  • Breast Cancer update 2014. 
    1/5/2015
  • Join now to see all

Other

  • "Bethesda Handbook of Clinical Oncology, Fourth Edition, (ISBN: 0-787-2300-0) Lippincott-Williams and Wilkins, Philadelphia" 
    Jame Abraham MD, Carmen Allegra MD, and James Gulley MD, PhD, National Cancer Institute, National Institutes of Health (Editors)
    www.lww.com
    1/1/2014
  • Lessons from Pink. 
    Abraham J., Community Oncology
    1/1/2013
  • Eribulin: Novel Taxane for breast cancer. 
    Abraham J., Community Oncology
    1/1/2010
  • Join now to see all

Authored Content

  • All the News That's Fit to Tweet: ESMO 2020September 2020
  • 3 Studies Presented at SABCS That Will Change Our PracticeDecember 2019
  • 3 Studies Presented at SABCS That Will Change Our PracticeDecember 2019
  • 'What Special Area of Knowledge Do You Bring to the Oncology World?'June 2019
  • 'What Special Area of Knowledge Do You Bring to the Oncology World?'June 2019
  • Join now to see all

Press Mentions

  • Indian American Dr Jame Abraham Appointed Department Chair of Hematology/Medical Oncology at Cleveland Clinic
    Indian American Dr Jame Abraham Appointed Department Chair of Hematology/Medical Oncology at Cleveland ClinicOctober 5th, 2019
  • Cleveland Clinic Appoints Dr. Jame Abraham as Department Chair of Hematology/Medical Oncology
    Cleveland Clinic Appoints Dr. Jame Abraham as Department Chair of Hematology/Medical OncologySeptember 23rd, 2019
  • Neratinib in Combo with T-dM1 Shows Promise for Advanced HER2+ Breast Cancer
    Neratinib in Combo with T-dM1 Shows Promise for Advanced HER2+ Breast CancerAugust 29th, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Urdu